Publications by authors named "Christine Codding"

Claim this Profile
T
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.
Mark C Genovese, Maria W Greenwald, Sergio R Gutierrez-Ureña, Mario H Cardiel, Jeffrey E Poiley, Christine E Codding

Rheumatol Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study.
Francisco J Blanco, Rüdiger Möricke, Eva Dokoupilova, Christine Codding, Jeffrey Neal

Arthritis Rheumatol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.
Mark C Genovese, Maria Greenwald, Christine Codding, Anna Zubrzycka-Sienkiewicz, Alan J Kivitz

Arthritis Rheumatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.
Iain B McInnes, Liz Thompson, Jon T Giles, Joan M Bathon, Jane E Salmon, Christine E Codding

Ann Rheum Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study.
Mark C Genovese, Patrick Durez, Hanno B Richards, Jerzy Supronik, Eva Dokoupilova, Christine E Codding

J Rheumatol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Mark C Genovese, Patrick Durez, Hanno B Richards, Jerzy Supronik, Eva Dokoupilova, Christine E Codding

Ann Rheum Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study.
Michael Schiff, Mauro Keiserman, Christine Codding, Suthin Songcharoen, Alberto Berman

Ann Rheum Dis· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
Clifton O Bingham, R John Looney, Atul Deodhar, Neal Halsey, Maria Greenwald, Christine Codding

Arthritis Rheum· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
Deborah A Marshall, Marcie E Strauss, Dan Pericak, Melanie Buitendyk, Christine Codding

Am J Manag Care· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis